50 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Biotech Stock Roundup: AMRN Stock Up, Pipeline Updates from GILD, BIIB, AMGN & More http://www.zacks.com/stock/news/677081/biotech-stock-roundup-amrn-stock-up-pipeline-updates-from-gild-biib-amgn-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-677081 Dec 18, 2019 - The biotech sector was in focus this week with pipeline and regulatory updates from quite a few players.
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition https://www.fool.com/investing/2019/12/21/how-gilead-sciences-is-helping-fund-bristol-myers.aspx?source=iedfolrf0000001 Dec 21, 2019 - But the big biotech isn't a happy camper about its contribution.
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again http://www.zacks.com/stock/news/705042/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-705042 Jan 06, 2020 - Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer http://www.zacks.com/stock/news/709625/mercks-keytruda-gets-fda-nod-for-high-risk-bladder-cancer?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-709625 Jan 09, 2020 - Merck's (MRK) Keytruda gets FDA's approval to treat certain patients with high-risk, non-muscle invasive bladder cancer.
Amgen Inc. (AMGN) CEO Bob Bradway Presents at 38th Annual J.P. Morgan Healthcare Conference Call (Transcript) https://seekingalpha.com/article/4316911-amgen-inc-amgn-ceo-bob-bradway-presents-38th-annual-j-p-morgan-healthcare-conference-call?source=feed_sector_transcripts Jan 14, 2020 -
Top Stock Reports for Alphabet, JPMorgan & Comcast http://www.zacks.com/research-daily/726570/top-stock-reports-for-alphabet-jpmorgan-comcast?cid=CS-ZC-FT-research_daily-726570 Jan 20, 2020 - Top Stock Reports for Alphabet, JPMorgan & Comcast
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth http://www.zacks.com/stock/news/730796/amgen-amgn-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-730796 Jan 23, 2020 - Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences? https://www.fool.com/investing/2020/01/26/which-big-biotech-has-the-safer-dividend-amgen-or.aspx?source=iedfolrf0000001 Jan 26, 2020 - Both biotechs claim attractive dividends. But one dividend appears to be at least a little safer than the other.
Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More http://www.zacks.com/stock/news/738675/big-drug-biotech-stock-earnings-on-jan-30-biib-alxn-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-738675 Jan 29, 2020 - Let us take a look at five big drug/biotech companies due to release their quarterly results on Jan 30.
Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4320434-amgen-inc-amgn-ceo-bob-bradway-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Jan 30, 2020 - Amgen Inc. (NASDAQ:AMGN) Q4 2019 Earnings Conference Call January 30, 2020, 05:00 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO Murdo Gordon - Hea

Pages: 12345

<Page 2>